Prebys Foundation is excited to announce the launch of the Prebys Ventures Impact Fund (Prebys Ventures), a $50 million impact investment fund dedicated to driving growth and technological advancement ...
Novartis is acquiring Anthos Therapeutics for up to $3.08 billion, adding abelacimab, a late-stage anticoagulant, to its ...
Belite Bio, Inc ("BLTE" or the "Company") (Nasdaq: BLTE), a clinical-stage biopharmaceutical drug development company focused ...
Neurocrine Biosciences exceeded earnings expectations for Q4 2024, driven by robust sales from key product Ingrezza, while ...
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...
SAN DIEGO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO), today reported financial results for the second quarter ended Dec. 31, ...
IgGenix, Inc., a clinical-stage biotechnology company pioneering innovative treatments for immune-mediated diseases, today announced the upcoming presentation of new data at the 2025 American Academy ...
News Medical on MSN1d
Cancer's ripple effect may promote blood clot formation in the lungsBlood clots form in response to signals from the lungs of cancer patients—not from other organ sites, as previously ...
Blood clots form in response to signals from the lungs of cancer patients—not from other organ sites, as previously ...
ASCO Genitourinary Cancers Symposium approaches, several highly anticipated studies are set to shape the future of treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback